Impaired Sensitivity to Thyroid Hormones is Associated with Mild Cognitive Impairment in Euthyroid Patients with Type 2 Diabetes
Zi-Wei Yu,Sheng-Dan Pu,Xiao-Tong Sun,Xi-Chang Wang,Xin-Yuan Gao,Zhong-Yan Shan
DOI: https://doi.org/10.2147/cia.s413584
IF: 3.829
2023-08-04
Clinical Interventions in Aging
Abstract:Zi-Wei Yu, 1, &ast Sheng-Dan Pu, 2, &ast Xiao-Tong Sun, 2 Xi-Chang Wang, 1 Xin-Yuan Gao, 2 Zhong-Yan Shan 1 1 Department of Endocrinology and Metabolism and the Institute of Endocrinology, The NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, First Hospital of China Medical University, Shenyang, 110001, People's Republic of China; 2 Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhong-Yan Shan; Xin-Yuan Gao, Tel +8613804905018 ; +8613904517001, Email ; Purpose: The prevalence of mild cognitive impairment (MCI) in patients with type 2 diabetes (T2D) is rapidly increasing. Thyroid hormones are key regulators of cognitive function in adults. The purpose of this study was to investigate the relationship between thyroid hormone sensitivity and MCI in euthyroid T2D patients. Patients and Methods: A total of 400 euthyroid T2D patients were enrolled in this cross-sectional study, including 218 patients with normal cognition and 182 MCI patients. The Montreal Cognitive Assessment (MoCA) was used to evaluate cognitive function. The free triiodothyronine to free thyroxine (FT3/FT4) ratio was calculated as a measure of peripheral sensitivity to thyroid hormones; the thyroid-stimulating hormone index (TSHI), thyrotrophic thyroxine resistance index (TT4RI) and thyroid feedback quantile-based index (TFQI) were calculated as measures of central sensitivity to thyroid hormones. Linear regression analysis and logistic regression analysis were performed to explore the relationships between these indices of thyroid hormone sensitivity and the MoCA score and MCI, respectively. Results: Compared with the normal cognitive function group, patients in the MCI group had higher TSHI, TT4RI and TFQI but a lower FT3/FT4 ratio ( P < 0.05). The MoCA score was positively correlated with the FT3/FT4 ratio but negatively correlated with TSHI, TT4RI and TFQI ( P < 0.05). Multivariate logistic regression analysis showed that a low FT3/FT4 ratio and high TSHI, TT4RI and TFQI were independently associated with MCI ( P < 0.05). After adjustment for confounding factors, the odds ratio (OR) for the association between MCI and the highest tertile of the FT3/FT4 was 0.455 (95% CI: 0.264– 0.785), for the highest tertile of TSHI, the OR was 2.380 (95% CI: 1.376– 4.119), for the highest tertile of TT4RI, the OR was 2.342 (95% CI:1.353– 4.054), and for the highest tertile of TFQI, the OR was 2.536 (95% CI: 1.466– 4.387) ( P < 0.05). Conclusion: Impaired sensitivity to thyroid hormones is associated with MCI in euthyroid T2D patients. Keywords: type 2 diabetes, mild cognitive impairment, thyroid hormones, sensitivity to thyroid hormones The type 2 diabetes (T2D) epidemic is a global public health problem. The burden of T2D and its associated complications is rapidly increasing. 1 Aside from the traditional macrovascular and microvascular complications, mild cognitive impairment (MCI; an intermediate stage between healthy aging and dementia) and dementia are also closely associated with T2D. 2 A cohort study revealed that T2D can increase the risk of MCI by 1.39 times. 3 More concerning is that T2D can also accelerate the conversion of MCI to dementia, thus affecting the quality of life of patients and aggravating the burden on families and society. 4 Therefore, it is of great clinical significance to identify and manage MCI in T2D patients as soon as possible. Thyroid hormones are known to play an important role in maintaining cognitive function during both the prenatal developmental stage and adulthood. 5,6 Thyroid dysfunction is considered a risk factor for cognitive impairment. 7,8 Previous studies have confirmed that both overt hypothyroidism and overt hyperthyroidism are closely related to cognitive dysfunction. 9,10 Similarly, subclinical hypothyroidism and subclinical hyperthyroidism may also increase the risk of cognitive impairment. 10,11 Even in the euthyroid population, changes in serum thyroid-stimulating hormone (TSH) and thyroid hormones may affect cognitive function. A prospective cohort study found that a lower serum free triiodothyronine (FT3) level, but still within the normal range, was associated with an increased risk of Alzheimer's disease (AD). 12 Meta-analyses and observational studies have confirmed that high-normal serum free thyroxine (FT4) levels are associated with dementia. 13,14 Many epidemiological studies have reporte -Abstract Truncated-
geriatrics & gerontology,gerontology